Zidovudine (AZT) Tablets - Treatment for Feline Leukemia (FeLV) in Cats

Zidovudine (AZT) for Cat FeLV/FIV Treatment

Zidovudine (AZT) is a widely used antiviral medication that has increasingly been applied in the treatment of Feline Leukemia Virus (FeLV) and Feline Immunodeficiency Virus (FIV). As a reverse transcriptase inhibitor, Zidovudine effectively suppresses viral replication, helps restore the immune system, and improves the overall health of cats. It is suitable for the treatment of early and mid-stage FeLV and FIV infections.

Product Features and Benefits

• Effective Viral Suppression: Zidovudine effectively inhibits the replication of FeLV and FIV, reducing viral load and halting disease progression.

• Immune System Support: By slowing the virus's impact on the immune system, Zidovudine helps restore immune function, reducing the risk of secondary infections.

• Clinical Symptom Improvement: After treatment with Zidovudine, common clinical symptoms such as weight loss, reduced appetite, and weakness significantly improve. Many cats show increased vitality, weight gain, and restored appetite.

Indications

Zidovudine is used to treat cats infected with:

• Feline Immunodeficiency Virus (FIV): Effective for cats with high viral loads.

• Feline Leukemia Virus (FeLV): Suitable for early or mid-stage FeLV-infected cats.

Dosage and Administration

• Recommended Dose: 3-5 mg per kg of body weight, typically administered orally every 12 hours.

• Treatment Duration: The standard treatment period ranges from 4 to 12 weeks, depending on the cat's infection level and clinical response. Long-term treatment may require an extended regimen.

Treatment Efficacy and Expected Outcomes

• FIV Treatment: Most cats will show initial improvements within 2-4 weeks, including weight recovery, improved mood, and increased appetite. Full therapeutic effects typically appear after 6-8 weeks of consistent treatment.

• FeLV Treatment: Cats will typically see improvements in weight, appetite, and immune function within 4-6 weeks. For cats with significant immune damage, the response may be slower, but Zidovudine still effectively slows disease progression.

Side Effects and Considerations

• Side Effects: Common side effects may include anemia, leukopenia (low white blood cell count), and elevated liver enzymes, especially with long-term use. Regular blood monitoring is essential.

• Bone Marrow Suppression: Long-term use may lead to bone marrow suppression, so periodic blood tests are necessary, and dosages may need adjustment.

• Drug Interactions: Zidovudine may interact with other medications, particularly antiviral or immunosuppressive drugs. Always consult your veterinarian before using Zidovudine in combination with other treatments.

Comprehensive Treatment Recommendations

• Combination Therapy: To maximize efficacy and reduce the risk of resistance, Zidovudine can be used alongside other antiviral or adjunctive treatments. Consult your veterinarian for the best approach.

Why Choose Zidovudine?

• Proven Antiviral Effectiveness: Zidovudine has been clinically validated to effectively suppress FIV and FeLV replication, reducing immune system damage.

• Clinically Supported: Studies show that Zidovudine improves clinical symptoms and extends survival, particularly in early and mid-stage FIV and FeLV infections.

• Safety and Scientific Backing: Zidovudine’s safety profile has been established through clinical trials. It should be administered under the guidance of a veterinarian.

Purchase Recommendation

Please consult with your veterinarian to determine the appropriate dosage and treatment plan based on your cat’s weight, health status, and the severity of the infection. If you have any questions or encounter issues during treatment, feel free to reach out to our expert team for guidance and support.

Together, let’s provide the best care for your cat, ensuring a healthier, more vibrant life during FIV and FeLV treatment!